JP6326611B2 - Cma生成阻害剤 - Google Patents
Cma生成阻害剤 Download PDFInfo
- Publication number
- JP6326611B2 JP6326611B2 JP2012247865A JP2012247865A JP6326611B2 JP 6326611 B2 JP6326611 B2 JP 6326611B2 JP 2012247865 A JP2012247865 A JP 2012247865A JP 2012247865 A JP2012247865 A JP 2012247865A JP 6326611 B2 JP6326611 B2 JP 6326611B2
- Authority
- JP
- Japan
- Prior art keywords
- camellia
- extract
- cma
- production
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 61
- 239000003112 inhibitor Substances 0.000 title claims description 18
- 240000001548 Camellia japonica Species 0.000 claims description 73
- 235000018597 common camellia Nutrition 0.000 claims description 64
- 239000000284 extract Substances 0.000 claims description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 10
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 10
- 229930182490 saponin Natural products 0.000 claims description 9
- 150000007949 saponins Chemical class 0.000 claims description 9
- 235000017709 saponins Nutrition 0.000 claims description 9
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 8
- 235000008777 kaempferol Nutrition 0.000 claims description 8
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 6
- LJNDQMBPIQGDNB-YFKPBYRVSA-N (2s)-2-(carboxymethylamino)-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NCC(O)=O LJNDQMBPIQGDNB-YFKPBYRVSA-N 0.000 claims description 3
- 241000209507 Camellia Species 0.000 claims 3
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- 239000000523 sample Substances 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 20
- 102000008186 Collagen Human genes 0.000 description 17
- 108010035532 Collagen Proteins 0.000 description 17
- 229920001436 collagen Polymers 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 16
- 239000003814 drug Substances 0.000 description 16
- 239000002537 cosmetic Substances 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 12
- 235000013305 food Nutrition 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000002994 raw material Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 239000000654 additive Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- -1 kaempferol glycosides Chemical class 0.000 description 7
- 238000000605 extraction Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 235000014214 soft drink Nutrition 0.000 description 6
- 239000004071 soot Substances 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 5
- 235000005487 catechin Nutrition 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229950001002 cianidanol Drugs 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 5
- 150000007946 flavonol Chemical class 0.000 description 5
- 235000011957 flavonols Nutrition 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RWTCSOPMUDGZQL-UHFFFAOYSA-N Camelliasaponin C2 Natural products CC=C(/C)C(=O)OC1CC(C)(C)CC2C3=CCC4C5(C)CCC(OC6OC(CO)C(O)C(OC7OCC(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C6OC9OC(CO)C(O)C(O)C9O)C(C)(CO)C5CCC4(C)C3(C)CC(O)C12CO RWTCSOPMUDGZQL-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- YDGQDJXYFVWQDO-UHFFFAOYSA-N camelliasaponin B1 Natural products CC=C(/C)C(=O)OC1CC(C)(C)CC2C3=CCC4C5(C)CCC(OC6OC(CO)C(O)C(OC7OCC(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C6OC9OC(CO)C(O)C(O)C9O)C(C)(C=O)C5CCC4(C)C3(C)CC(O)C12CO YDGQDJXYFVWQDO-UHFFFAOYSA-N 0.000 description 3
- MGTOPLIWMNGFCQ-UHFFFAOYSA-N camelliasaponin B2 Natural products O=CC1(C)C2CCC3(C)C4(C)CC(O)C5(CO)C(OC(=O)C(C)=CC)CC(C)(C)CC5C4=CCC3C2(C)CCC1OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C(O)C1OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O MGTOPLIWMNGFCQ-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 235000020688 green tea extract Nutrition 0.000 description 3
- 229940094952 green tea extract Drugs 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KRGSIOSNSSCAMH-IHGNYCBKSA-N (2r,3s,6r)-6-[[(4r,4ar,6as,6bs,8ar,12as,14ar,14br)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-9-[(e)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-[(2s,3s,4r,5s)-4,5-dihydroxy-3-[(2s,3s,4r) Chemical compound O([C@H]1[C@H](O)[C@@H](O)CO[C@H]1OC1[C@H](O)[C@@H](O[C@H](C1O[C@H]1C(C(O)C(O)C(CO)O1)O)OC1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC([C@@]5(C(O)C[C@@]4(C)[C@@]3(C)CC[C@H]2[C@@]1(CO)C)CO)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1OC(CO)C(O)[C@@H](O)[C@@H]1O KRGSIOSNSSCAMH-IHGNYCBKSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 235000006467 Camellia japonica Nutrition 0.000 description 2
- KTCJGPRMIOCILW-UXZWGIKGSA-N Camelliasaponin A1 Natural products CC=C(C)C(=O)O[C@H]1CC(C)(C)C[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O)[C@H](O[C@@H]7OC[C@H](O)[C@H](O)[C@H]7O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]6O[C@@H]9O[C@H](CO)[C@H](O)[C@H](O)[C@H]9O)C(=O)O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@@H](O)[C@@]12CO KTCJGPRMIOCILW-UXZWGIKGSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000122501 Hypericum x moserianum Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 241000201142 Pitar Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- MGTOPLIWMNGFCQ-PGGKNCGUSA-N camelliasaponin b2 Chemical compound O=CC1(C)C2CCC3(C)C4(C)CC(O)C5(CO)C(OC(=O)C(/C)=C/C)CC(C)(C)CC5C4=CCC3C2(C)CCC1OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C(O)C1OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O MGTOPLIWMNGFCQ-PGGKNCGUSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000036252 glycation Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000012744 immunostaining Methods 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 230000003137 locomotive effect Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- RRUYWEMUWIRRNB-LURJTMIESA-N (2s)-6-amino-2-[carboxy(methyl)amino]hexanoic acid Chemical compound OC(=O)N(C)[C@H](C(O)=O)CCCCN RRUYWEMUWIRRNB-LURJTMIESA-N 0.000 description 1
- MGTOPLIWMNGFCQ-UOPXLPJJSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9s,12as,14ar,14br)-4-formyl-8-hydroxy-8a-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-9-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-[(2s,3r,4s,5s)-4,5-dihy Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)C[C@@H]([C@@]5([C@H](O)C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(C=O)C)CO)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O MGTOPLIWMNGFCQ-UOPXLPJJSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 235000015911 Amorpha canescens Nutrition 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 241001062622 Camellia granthamiana Species 0.000 description 1
- 241001548375 Camellia lutchuensis Species 0.000 description 1
- 241001343472 Camellia pitardii Species 0.000 description 1
- 240000006846 Camellia reticulata Species 0.000 description 1
- 241001552456 Camellia salicifolia Species 0.000 description 1
- 240000006833 Camellia sasanqua Species 0.000 description 1
- KTCJGPRMIOCILW-PHROOHHUSA-N Camelliasaponin A2 Natural products O=C(O[C@@H]1[C@]2(CO)[C@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H](C(C)(C)[C@@H](O[C@H]6[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O7)[C@@H](O[C@H]7[C@H](O[C@H]8[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O8)[C@@H](O)[C@@H](O)CO7)[C@H](O)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC(C)(C)C1)/C(=C\C)/C KTCJGPRMIOCILW-PHROOHHUSA-N 0.000 description 1
- KRGSIOSNSSCAMH-QPAGQQEASA-N Camelliasaponin C1 Natural products O([C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)C[C@@H]([C@@]5([C@H](O)C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(CO)C)CO)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KRGSIOSNSSCAMH-QPAGQQEASA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 244000107780 Capraria biflora Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000013629 Lippia javanica Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- HEZVPSGPLFBHPM-VROXFSQNSA-N camelliasaponin a1 Chemical compound CC1(C)C2CCC3(C)C4(C)CC(O)C5(CO)C(OC(=O)C(\C)=C/C)CC(C)(C)CC5C4=CCC3C2(C)CCC1OC(C(C1O)OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C1OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O HEZVPSGPLFBHPM-VROXFSQNSA-N 0.000 description 1
- HEZVPSGPLFBHPM-YSURURNPSA-N camelliasaponin a2 Chemical compound CC1(C)C2CCC3(C)C4(C)CC(O)C5(CO)C(OC(=O)C(/C)=C/C)CC(C)(C)CC5C4=CCC3C2(C)CCC1OC(C(C1O)OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C1OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O HEZVPSGPLFBHPM-YSURURNPSA-N 0.000 description 1
- KRGSIOSNSSCAMH-PGGKNCGUSA-N camelliasaponin c1 Chemical compound OCC1(C)C2CCC3(C)C4(C)CC(O)C5(CO)C(OC(=O)C(/C)=C/C)CC(C)(C)CC5C4=CCC3C2(C)CCC1OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C(O)C1OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O KRGSIOSNSSCAMH-PGGKNCGUSA-N 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 244000192963 common camellia Species 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 108010004903 glycosylated serum albumin Proteins 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- AYEKKSTZQYEZPU-RYUDHWBXSA-N pentosidine Chemical compound OC(=O)[C@@H](N)CCCCN1C=CC=C2N=C(NCCC[C@H](N)C(O)=O)N=C12 AYEKKSTZQYEZPU-RYUDHWBXSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
(1)ツバキ(Camellia)属ツバキ節に属する植物を有効成分として含有してなるCMA生成阻害剤である。
(2)該剤において、ツバキ(Camellia)属ツバキ節に属する植物が、ヤブツバキ、ユキツバキ、リンゴツバキ、ホウザンツバキ、ホンコンツバキ、ピタールツバキ及び金花茶からなる群から選ばれる1種又は2種以上であり、その実若しくは種子を水及び/又は親水性有機溶媒で抽出処理して得られる水性成分を含むものであることが望ましい。
(3)前記ツバキの実又は種子は、予め脱脂処理されたものであることが望ましい。
(4)前記ツバキの抽出物はサポニン類を含むものが好ましく、該サポニン類はとりわけカメリアサポニン(Camelliasaponin)A1、カメリアサポニンA2、カメリアサポニンB1、カメリアサポニンB2、カメリアサポニンC1及びカメリアサポニンC2からなる群から選ばれる1種又は2種以上であることが望ましく、少なくともカメリアサポニンB2及び/又はカメリアサポニンC2であることがより望ましい。
(5)前記CMA生成阻害剤は、これを経口で摂取又は皮膚に塗布することにより、皮膚の美容のために利用される。
ヤブツバキ(C.japonica var.japonica:長崎県五島産)の乾 燥種子を粗粉砕して蒸煮後、圧搾して圧搾油を分離した圧搾粕を得、次いで圧搾粕にノルマルヘキサンを加えて常法により抽出処理し、抽出液を分離して抽出粕を得た。この抽出粕をノルマルヘキサンで洗浄して油分を取り除き脱脂粕を採取した。この脱脂粕100gに水800mLを加え、常圧下、80〜85℃に加熱して1時間適宜に撹拌した後、室温まで冷却し、濾過して濾液を分離した。この濾過残渣に再度水600mLを加えて同様に加熱し、冷却後、濾過して濾液を採取した。両濾液を合わせて減圧下に濃縮し、凍結乾燥及び粉砕して抽出物(試料1)16.3gを調製した。この抽出物をHPLC分析した結果、カメリアサポニンB2及びC2、フラボノールの一種であるケンフェロールが含まれていることを確認した。
リンゴツバキ(C.japonica var.macrocarpa:鹿児島県屋久島産)の乾燥種子を製造例1に記載の方法で脱脂して脱脂粕を採取した。この脱脂粕100gに水400mLを加え、2気圧の加圧下、120℃で20分間加熱した後、室温まで冷却し、濾過して濾液を分離した。この濾過残渣に再度水300mLを加えて同様に加熱し、冷却後、濾過して濾液を採取した。両濾液を合わせて減圧下に濃縮し、凍結乾燥及び粉砕して抽出物(試料2)18.7gを調製した。この抽出物を製造例1と同様に処理して分析した結果、カメリアサポニンB2及びC2、フラボノールの一種であるケンフェロールが含まれていることを確認した。
製造例1に記載の方法で得た脱脂粕100gに含水エタノール(含水率35%)400mLを加え、75〜80℃で1時間加熱還流した後、室温まで冷却し、濾過して濾液を分離した。この濾過残渣に再度含水エタノール(含水率35%)300mLを加えて同様に加熱し、冷却後、濾過して濾液を採取した。両濾液を合わせて減圧下に濃縮し、凍結乾燥及び粉砕して抽出物(試料3)12.6gを調製した。この抽出物を製造例1と同様に処理及び分析した結果、カメリアサポニンB2及びC2、フラボノールの一種であるケンフェロールが含まれていることを確認した。
製造例1に記載の方法で得た脱脂粕100gにエタノール(純度99.5%)400mLを加え、約80℃で1時間加熱還流した後、室温まで冷却し、濾過して濾液を分離した。この濾過残渣に再度エタノール(純度99.5%)300mLを加えて同様に加熱し、冷却後、濾過して濾液を採取した。両濾液を合わせて減圧下に濃縮し、凍結乾燥及び粉砕して抽出物(試料4)4.5gを調製した。この抽出物を製造例1と同様に処理し分析した結果、カメリアサポニンB2及びC2、フラボノールの一種であるケンフェロールが含まれていることを確認した。
製造例1において、乾燥種子を未熟実(種子を含む実全体)に代えて同様に処理して、脱脂粕を得た後、これから抽出物(試料5)17.5gを調製した。この抽出物を製造例1と同様に処理し分析した結果、カメリアサポニンB2及びC2、フラボノールの一種であるケンフェロールが含まれていることを確認した。
検体としてツバキ抽出物(試料1〜試料5)を用い、比較対象試料として、AGハーブMIX(アークレイ(株)製、比較試料1)、及び、CMA生成阻害作用が既知のカテキン(ナカライテスク(株)製、比較試料2)を用いてCMA生成阻害作用を試験した。
CMA生成阻害率(%)={1−(対照−試料)/(対照−ブランク)}×100
糖尿病モデル動物におけるCMA生成阻害作用について以下の方法で試験した。すなわち、5週齢雄性KK−Ayマウス(日本クレア(株)から購入。)を1週間予備飼育した後、1群3匹として、コントロール群、本発明試料(試料1〜試料5)投与群、比較試料2投与群、及び、ツバキ抽出物の製造過程で得られたツバキ油を投与する群に群分けした。各群のマウスに標準飼料(CE−2、日本クレア(株)製)に、それぞれの試料を1%となるように配合した試験飼料を与えて12週間飼育した。
以下の試験に同意を得たボランティアの成人女性30名(35歳〜55歳、平均年齢:43.5歳)に、1群10名でプラセボ(精製水)塗布群、精製水に1%に溶解した試料1又は比較試料2を塗布する群の3群に分かれてもらい、1日3回、8週間、適量を顔に塗布し、塗布試験の終了時に肌のシワに関するアンケート調査によって評価を行った。
以下に示す原料を常法により打錠して錠剤を試作した。ここで、ツバキ抽出物としては、前記の製造例1〜4で得たツバキ抽出物のいずれか1種を使用した。これらの錠剤はいずれも安定で服用し易いものであり、栄養補助食品や医薬品として利用することができる。なお、本錠剤(製造例1のツバキ抽出物を配合したもの)をモニター試験で経口摂取してもらったところ、肌のシワ、弾力性等の改善が認められる知見を得た。したがって、本錠剤は美容のための食品あるいは内服薬として利用することができる。
1.ツバキ抽出物 10
2.乳糖 190
3.バレイショデンプン 39
4.微結晶セルロース 30
5.合成ケイ酸アルミニウム 30
6.ステアリン酸カルシウム 1
前記の製造例2のツバキ抽出物及び緑茶エキス(ビーエイチエヌ(株)製)を1:1の比率で均一に混合して本発明の混合物を作成した。この1gを市販の清涼飲料水500mLに加えて溶かし、CMA生成阻害用の清涼飲料水を試作した。これは元の清涼飲料水と比較して何ら遜色のないものであった。これは清涼飲料又はドリンク剤として利用することが可能である。
ツバキの含水エタノール抽出物として製造例3の抽出物を用い、以下の処方で常法により乳液を試作した。この乳液は、使用感に優れており、皮膚に塗布してシワやシミの予防、肌の柔軟性や弾力性を維持するための外用剤として使用することができる。
1.スクワラン 5.0
2.オリーブ油 5.0
3.ホホバオイル 5.0
4.セチルアルコール 1.5
5.グリセリンモノステアレート 2.0
6.ポリオキシエチレン(20)セチルエーテル 3.0
7.ポリオキシエチレン(20)ソオルビタンモノオレート 2.0
8.1,3−ブチレングリコール 1.0
9.グリセリン 2.0
10.ツバキ含水エタノール抽出物 5.0
11.香料 適 量
12.防腐剤 適 量
13.精製水
ツバキ種子のエタノール抽出物として製造例4の抽出物を用い、以下の処方で常法によりローションを試作した。
1.ツバキ抽出物 0.1
2.緑茶エキス 0.01
3.α−トコフェロール 0.1
4.アスコルビン酸 0.5
5.ジプロピレングリコール 15
6.イソステアリン酸ポリオキシエチレンソルビタン 0.5
7.ヒドロキシエチルセルロース 0.01
8.香料 適 量
9.防腐剤 適 量
10.精製水
Claims (1)
- ツバキ(Camellia)属ツバキ節に属する植物の種子から採取した脱脂粕を、水で抽出して得られる抽出物を有効成分として含有してなるカルボキシメチルアルギニン生成阻害剤を製造する方法。ここで、前記植物はヤブツバキ、ユキツバキ、リンゴツバキ、ホウザンツバキ、ホンコンツバキ、ピタールツバキ及び金花茶からなる群から選ばれる1種又は2種以上であり、前記抽出物は少なくともカメリアサポニンB2及びC2を含有し、かつ、前記抽出物の加水分解物が少なくともケンフェロールを含有するものである。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012247865A JP6326611B2 (ja) | 2012-10-24 | 2012-10-24 | Cma生成阻害剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012247865A JP6326611B2 (ja) | 2012-10-24 | 2012-10-24 | Cma生成阻害剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018048957A Division JP2018090639A (ja) | 2018-03-16 | 2018-03-16 | Cma生成阻害剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014084321A JP2014084321A (ja) | 2014-05-12 |
JP6326611B2 true JP6326611B2 (ja) | 2018-05-23 |
Family
ID=50787726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012247865A Active JP6326611B2 (ja) | 2012-10-24 | 2012-10-24 | Cma生成阻害剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6326611B2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021116275A (ja) * | 2020-01-28 | 2021-08-10 | 株式会社 Mtg | 椿の抽出物及びその製造方法 |
JP7166577B1 (ja) * | 2021-04-23 | 2022-11-08 | 一丸ファルコス株式会社 | コラーゲン産生促進剤及びそれを含む皮膚外用剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080138481A1 (en) * | 2006-12-07 | 2008-06-12 | Chi-Tang Ho | Methods of reducing reactive carbonyl species |
JP5301135B2 (ja) * | 2007-10-15 | 2013-09-25 | 竜児 永井 | カルボキシメチルアルギニン生成抑制剤 |
JP5983908B2 (ja) * | 2007-12-27 | 2016-09-06 | ビーエイチエヌ株式会社 | 抗炎症剤および皮膚外用品 |
JP5685752B2 (ja) * | 2009-05-13 | 2015-03-18 | ビーエイチエヌ株式会社 | 血流促進改善剤 |
WO2011004734A1 (ja) * | 2009-07-08 | 2011-01-13 | アークレイ株式会社 | カルボキシメチルアルギニン生成抑制剤およびコラーゲン変性抑制剤 |
-
2012
- 2012-10-24 JP JP2012247865A patent/JP6326611B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2014084321A (ja) | 2014-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6674001B2 (ja) | メイラード反応阻害剤 | |
JP5685752B2 (ja) | 血流促進改善剤 | |
JP2010202520A (ja) | 皮膚改善剤及び美容健康用経口組成物 | |
JP2022173481A (ja) | コラゲナーゼ阻害剤 | |
JP5617110B2 (ja) | 経口発毛促進剤 | |
JP2002293736A (ja) | メーラード反応阻害剤およびそれを含有する組成物 | |
JP5597828B2 (ja) | 育毛剤 | |
JP2005029486A (ja) | 皮膚改善組成物 | |
JP5027361B2 (ja) | ヒアルロン酸産生促進剤 | |
JP2013184974A (ja) | メイラード反応抑制剤及びその利用 | |
JP6055667B2 (ja) | コラーゲン産生促進剤 | |
JP6326611B2 (ja) | Cma生成阻害剤 | |
JP6108352B2 (ja) | 疲労改善組成物 | |
JP6718158B2 (ja) | 肝機能改善剤 | |
JP7296611B2 (ja) | 一酸化窒素産生促進剤 | |
JP2018090639A (ja) | Cma生成阻害剤 | |
JP2004149729A (ja) | 抗酸化剤 | |
KR20220112888A (ko) | 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물 | |
JP2011032177A (ja) | Kit切断抑制剤 | |
KR20210006192A (ko) | 색도가 감소된 홍삼 추출물의 제조 방법 | |
JP7320270B2 (ja) | 肝機能改善剤 | |
JP7166840B2 (ja) | 発毛促進、脱毛防止又はキューティクル改善用組成物及び創傷治癒剤 | |
JP7262319B2 (ja) | メラニン生成抑制剤、及びメラニン生成抑制剤の製造方法 | |
JP2002161042A (ja) | 抗酸化剤 | |
JP6022333B2 (ja) | セラミド産生促進剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151013 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160825 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160906 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161107 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170529 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170808 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171006 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171124 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171207 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180316 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6326611 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |